drugset / Trial / NCT00404586
Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber
RandomizedCrossoverTreatment
Summary
This study was designed to look at safety aspects and effects of intranasal doses of GW784568X on allergic rhinitis symptoms to develop this drug for its use in people who suffer with allergic rhinitis
Timeline
- Start
- 2006-09-11
- Primary completion
- 2007-01-16
- Completion
- 2007-01-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GW784568X | Unknown | 100 ug | Intranasal |
| Subject | GW784568X | Unknown | 200 ug | Intranasal |
| Subject | GW784568X | Unknown | 400 ug | Intranasal |
| Background | Fluticasone propionate | Other / unclassified | 200 ug | Intranasal |